Latest news

Insights

Top 10 Technologies Improving Patient Retention

Executive Summary Maintaining patient engagement throughout treatment is a growing priority for pharmaceutical companies and healthcare providers. Patients may discontinue...
Insights

Building AI-Ready Data Platforms in Life Sciences

Executive Summary Artificial intelligence is becoming central to pharmaceutical research, clinical development, manufacturing, and commercial operations. Yet many organizations struggle...
Clinical

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Phase 3 Success and Primary Endpoint Achieved InventisBio's nomelcitinib met its primary endpoint in a phase 3 trial, providing proof...
Clinical

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Teva Pharmaceuticals is discontinuing its Phase 2 clinical trial of emrusolmin, an experimental oral drug being investigated for multiple...
Commercial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Financial Terms and Partnership Scope Astellas has agreed to up...
Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has...
Clinical

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Novartis reported late-stage clinical trial failures for two experimental medicines in September, including del-desiran, which was being developed for...
Insights

Top 10 Metrics Clinical Operations Leaders Should Track

Executive Summary Clinical operations leaders must balance trial speed, cost, quality, participant safety, and operational reliability. As studies become more...
Commercial

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Georgiamune, a Maryland-based biotechnology company focused on immunology, has licensed an experimental cancer treatment to Stemline Therapeutics, a subsidiary...
Clinical

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Following Lisraya’s first regulatory approval, Roivant and its subsidiary...
Clinical

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

Bristol Myers Squibb (BMS) has reported positive results from...
Clinical

BioNTech Reports Modest Benefit and Safety Concerns in Phase 3 Breast Cancer Trial

BioNTech and DualityBio have reported topline results from DYNASTY-Breast02, a global phase 3 clinical trial evaluating trastuzumab pamirtecan (t-pam)...
Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense oligonucleotide licensed from Ionis Pharmaceuticals, marking a milestone in the...
Insights

Real-Time Commercial Intelligence in Life Sciences

Executive Summary Pharmaceutical commercial teams are operating in markets where competitive activity, treatment preferences, access conditions, and customer expectations can...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

United Health Group Acquires New York-Based Physician Group

NewYork-based healthcare company Crystal Run has been reportedly purchased...
Commercial

McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology

McKesson has planned to enhance its oncology platform with...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Insights

Building AI-Ready Data Platforms in Life Sciences

Executive Summary Artificial intelligence is becoming central to pharmaceutical research,...
Clinical

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Phase 3 Success and Primary Endpoint Achieved InventisBio's nomelcitinib met...
Clinical

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Teva Pharmaceuticals is discontinuing its Phase 2 clinical trial...
Insights

Top 10 Digital Capabilities Separating Industry Leaders

Executive Summary Digital maturity is becoming a competitive differentiator across...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Technologies Improving Patient Retention

Executive Summary Maintaining patient engagement throughout treatment is a growing...
Editorial Team -
Clinical

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Phase 3 Success and Primary Endpoint Achieved InventisBio's nomelcitinib met...
Editorial Team -